1. Home
  2. BMRN vs PR Comparison

BMRN vs PR Comparison

Compare BMRN & PR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • PR
  • Stock Information
  • Founded
  • BMRN 1996
  • PR 2015
  • Country
  • BMRN United States
  • PR United States
  • Employees
  • BMRN 3040
  • PR N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • PR Oil & Gas Production
  • Sector
  • BMRN Health Care
  • PR Energy
  • Exchange
  • BMRN Nasdaq
  • PR Nasdaq
  • Market Cap
  • BMRN 9.9B
  • PR 9.3B
  • IPO Year
  • BMRN 1999
  • PR 2016
  • Fundamental
  • Price
  • BMRN $51.46
  • PR $13.26
  • Analyst Decision
  • BMRN Buy
  • PR Strong Buy
  • Analyst Count
  • BMRN 19
  • PR 14
  • Target Price
  • BMRN $90.26
  • PR $18.38
  • AVG Volume (30 Days)
  • BMRN 2.9M
  • PR 11.1M
  • Earning Date
  • BMRN 10-27-2025
  • PR 11-05-2025
  • Dividend Yield
  • BMRN N/A
  • PR 4.52%
  • EPS Growth
  • BMRN 59.53
  • PR N/A
  • EPS
  • BMRN 2.68
  • PR 1.12
  • Revenue
  • BMRN $3,094,001,000.00
  • PR $5,191,924,000.00
  • Revenue This Year
  • BMRN $13.32
  • PR $7.34
  • Revenue Next Year
  • BMRN $7.51
  • PR $0.97
  • P/E Ratio
  • BMRN $19.20
  • PR $11.82
  • Revenue Growth
  • BMRN 12.39
  • PR 7.55
  • 52 Week Low
  • BMRN $50.76
  • PR $10.01
  • 52 Week High
  • BMRN $73.51
  • PR $16.33
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 40.53
  • PR 58.04
  • Support Level
  • BMRN $51.80
  • PR $12.07
  • Resistance Level
  • BMRN $53.49
  • PR $12.62
  • Average True Range (ATR)
  • BMRN 1.84
  • PR 0.35
  • MACD
  • BMRN -0.08
  • PR 0.09
  • Stochastic Oscillator
  • BMRN 12.58
  • PR 97.41

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

About PR Permian Resources Corporation

Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization and development of oil and liquids-rich natural gas assets. The Company's assets and operations are concentrated in the core of the Permian Basin, and its properties consist of large, contiguous acreage blocks located in West Texas and New Mexico.

Share on Social Networks: